Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
The platform integrates fat removal, closed-loop contouring, tissue contraction, and electrosurgical capabilities.
Allergan Aesthetics’ Heidi Shurtz discusses updates to the APP loyalty program, including simplified savings, greater pricing transparency, and new benefits for growing aesthetics practices.